Long acting injection versus oral risperidone in first-episode schizophrenia: differential impact on white matter myelination trajectory.
about
Review of depot aripiprazole for schizophreniaOligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia.White matter alterations in bipolar disorder: potential for drug discovery and development.The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.Indirect association of DAT1 genotype with executive function through white matter volume in orbitofrontal cortex.Prolonged Subdural Infusion of Kynurenic Acid Is Associated with Dose-Dependent Myelin Damage in the Rat Spinal CordRole of long-acting injectable second-generation antipsychotics in the treatment of first-episode schizophrenia: a clinical perspective.Long-acting injectable antipsychotics for first-episode schizophrenia: the pros and cons.Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia.Wisconsin Card Sorting Test scores and clinical and sociodemographic correlates in Schizophrenia: multiple logistic regression analysis.Levels of Red Blood Cell Fatty Acids in Patients With Psychosis, Their Unaffected Siblings, and Healthy ControlsImpact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia.White matter changes associated with antipsychotic treatment in first-episode psychosis.Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.Should long-acting (depot) antipsychotics be used in early schizophrenia? A systematic review.Long-acting injectable antipsychotics in early psychosis: a literature review.Long-acting injectable formulations of new-generation antipsychotics: a review from a clinical perspective.Treatment effect with paliperidone palmitate compared with oral antipsychotics in patients with recent-onset versus more chronic schizophrenia and a history of criminal justice system involvement.The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.Clinical benefits and impact of early use of long-acting injectable antipsychotics for schizophrenia.Pharmacological treatment of schizophrenia with comorbid substance use disorder.Remyelination: A Potential Therapeutic Strategy for Alzheimer's Disease?Paliperidone Palmitate Once-Monthly Treatment in Recent Onset and Chronic Illness Patients With Schizoaffective Disorder.Long-acting Injectable Antipsychotics in First-episode Schizophrenia.Targeted multiplexed selected reaction monitoring analysis evaluates protein expression changes of molecular risk factors for major psychiatric disorders.Long-acting injectable antipsychotics in first-episode schizophrenia.Once-monthly injection of paliperidone palmitate in patients with recently diagnosed and chronic schizophrenia: a post-hoc comparison of efficacy and safety.Increased body mass index makes an impact on brain white-matter integrity in adults with remitted first-episode mania.Factors related to improvement of symptoms, function, and caregiver burden in Chinese patients with schizophrenia after switching to paliperidone palmitate once-monthly from oral antipsychotics.Corpus callosum volumes in the 5 years following the first-episode of schizophrenia: Effects of antipsychotics, chronicity and maturation.Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics - expert consensus survey part 1.Fractional Anisotropic Changes of Corpus Callosum Associated with Antipsychotic Treatment in First-Episode Antipsychotic Drug-Naive Patients with Schizophrenia
P2860
Q27008464-EB773741-1C30-4418-B5FC-453714F6A5BBQ30405077-6157C96E-C5A1-4C21-8E80-C514C7427C2DQ34406905-EDC247F8-A394-4222-9B7D-1FCB966218B0Q34418847-FF28D18A-CACA-43E8-AF93-FED98E569320Q35498962-9A759222-9434-4834-8B0B-6669701FA52FQ35840053-87CE4B57-895E-4406-B37C-A79CE3B88811Q36168916-8F67CB89-8189-43D5-897A-6B0F4EE445BBQ36183650-A73436EA-33A3-4E76-B487-F9E13741D1C3Q36202865-57940499-3920-4F5D-B3AB-D5B12387FA24Q36496730-29002507-9FE3-41CC-87F6-F125716A41B2Q36580009-D18B8748-7217-4860-B943-4C51BE284503Q36597061-F8FFCCD8-6E6A-4B7D-A6DC-91F6293F197CQ37705723-8E419D57-D9F3-4869-B260-10257AEAD801Q37981491-77E5FB3A-AFBC-4425-A077-2C9AF7133B6AQ38064842-17E815A6-87EC-465D-93E3-08BBAE4124FAQ38076170-BBDC54C2-C8C5-454A-8F2E-DF5FEE46B069Q38115487-1F437774-0BE2-41B2-9998-EC9B8187026EQ38403164-DA01C3DD-F6D9-4AC2-B867-1577DD35DC4EQ38570636-E2BD7C72-CBE3-4577-9352-2458C2E18801Q38592404-42E36D0E-ACC7-4D02-9400-0B512AA3E1DDQ38658672-580A14C1-070A-46F3-9EB2-994E91333CB5Q38814687-413D14F7-114A-4389-BF4F-00631771612EQ39073819-FA20D711-BB4D-409D-A0F4-131350D2E646Q40597668-74BBC631-EE87-44B0-AEED-598533C9DAE5Q41651452-EF4400D0-851D-4616-A827-7C47F03467C3Q41991738-D3C6753B-1464-4667-931A-07FFE6B8D019Q47574118-AA11C8EA-32CD-4098-8CFE-88D489096CBCQ50706849-EB30D795-F036-462F-8B24-FFD5D3174A5FQ51731261-663AB237-4734-46B0-A22B-3BEA9292E943Q54965265-BC8A4E22-9E6D-46E4-BDF8-BEFCDE246042Q55364906-59C887DF-C5B8-4073-AD35-6ACDF79AAE17Q57820149-E3741F66-4BAE-4245-A3B3-F0179B122FD7
P2860
Long acting injection versus oral risperidone in first-episode schizophrenia: differential impact on white matter myelination trajectory.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Long acting injection versus o ...... matter myelination trajectory.
@ast
Long acting injection versus o ...... matter myelination trajectory.
@en
type
label
Long acting injection versus o ...... matter myelination trajectory.
@ast
Long acting injection versus o ...... matter myelination trajectory.
@en
prefLabel
Long acting injection versus o ...... matter myelination trajectory.
@ast
Long acting injection versus o ...... matter myelination trajectory.
@en
P2093
P2860
P1476
Long acting injection versus o ...... matter myelination trajectory.
@en
P2093
Chetan P Amar
Erika P Raven
George Bartzokis
John S Luo
Joseph Ventura
Kenneth L Subotnik
Laurie R Casaus
Lori L Altshuler
Nicole R Detore
P2860
P356
10.1016/J.SCHRES.2011.06.029
P407
P577
2011-07-20T00:00:00Z